ERBB2 and neoplasm: Additionally, abnormal HER2 signaling can increase the invasiveness and metastatic potential of tumor cells and activate multiple anti-apoptotic pathways, rendering tumor cells resistant to treatment (Spector and Blackwell, 2009; Citri and Yarden, 2006; Gutierrez and Schiff, 2011).